Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$1.49B |
| 2 |
FFEU
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
|
+$423M |
| 3 |
SLB Ltd
SLB
|
+$408M |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$340M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
HSBC
HSBC
$367B
| $702M | 0.93% |
15,776,588
+195,702
| +1% | +$9.31M |
|
27
PepsiCo
PEP
$191B
| $684M | 0.91% |
6,268,697
+187,669
| +3% | +$21.3M |
|
28
HDFC Bank
HDB
$124B
| $679M | 0.9% |
27,492,828
-4,218,160
| -13% | -$106M |
|
29
AB InBev
BUD
$166B
| $675M | 0.9% |
6,144,032
+147,016
| +2% | +$16.3M |
|
|
NVO
30
Novo Nordisk
NVO
$228B
| $647M | 0.86% |
26,259,314
+848,360
| +3% | +$22.3M |
|
31
Berkshire Hathaway Class B
BRK.B
$1.1T
| $637M | 0.84% |
3,191,835
+155,804
| +5% | +$32M |
|
|
BAY
32
DELISTED
BAYER AG SPONS ADR
BAY
| $612M | 0.81% |
21,668,714
+830,372
| +4% | +$23.4M |
|
33
Sanofi
SNY
$103B
| $604M | 0.8% |
15,073,452
+572,694
| +4% | +$23.8M |
|
34
Oracle
ORCL
$367B
| $602M | 0.8% |
13,151,741
+583,326
| +5% | +$29M |
|
35
Banco Santander
SAN
$202B
| $584M | 0.77% |
93,069,055
+3,917,330
| +4% | +$25.9M |
|
36
Novartis
NVS
$301B
| $566M | 0.75% |
7,819,225
+211,871
| +3% | +$16.1M |
|
37
JPMorgan Chase
JPM
$933B
| $550M | 0.73% |
5,003,395
+130,408
| +3% | +$14.8M |
|
|
FIEE
38
DELISTED
FI Enhanced Europe 50 ETN
FIEE
| $540M | 0.72% |
3,264,950
-4,113
| -0.1% | -$728K |
|
39
iShares MBS ETF
MBB
$39.1B
| $529M | 0.7% |
5,057,138
+461,572
| +10% | +$48.4M |
|
40
GSK
GSK
$104B
| $525M | 0.7% |
10,742,675
+518,898
| +5% | +$24.2M |
|
41
RTX Corp
RTX
$289B
| $495M | 0.66% |
6,254,949
+214,318
| +4% | +$17.7M |
|
42
Chevron
CVX
$383B
| $482M | 0.64% |
4,228,966
+191,111
| +5% | +$22.8M |
|
43
Sumitomo Mitsui Financial
SMFG
$164B
| $471M | 0.62% |
55,376,036
+2,429,565
| +5% | +$21.7M |
|
44
Costco
COST
$423B
| $469M | 0.62% |
2,488,816
+162,335
| +7% | +$30.6M |
|
45
Trip.com Group
TCOM
$29.3B
| $460M | 0.61% |
9,869,712
-198,741
| -2% | -$9.32M |
|
46
AstraZeneca
AZN
$266B
| $439M | 0.58% |
6,272,080
+313,414
| +5% | +$21.7M |
|
47
JD.com
JD
$43.6B
| $435M | 0.58% |
10,739,720
-244,901
| -2% | -$11.1M |
|
|
FFEU
48
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
| $431M | 0.57% |
+4,351,098
| New | +$423M |
|
49
Lloyds Banking Group
LYG
$90.7B
| $430M | 0.57% |
115,600,470
-7,405,788
| -6% | -$28.7M |
|
50
ASML
ASML
$634B
| $427M | 0.57% |
2,150,698
+75,417
| +4% | +$14.8M |
|
Similar funds
Ken Fisher's Q1 2018 Portfolio in Review
As of Q1 2018, Ken Fisher held 991 positions worth $75.4B, down 1.5% from $76.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher's Q1 2018 filing shows 69 new, 261 increased, 401 reduced and 162 closed positions. Its largest new stake was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B. The largest sale was Barclays ETN+ FI Enhanced Global High Yield ETN, an estimated $1.59B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Ken Fisher's largest Q1 2018 buy was Barclays ETN+ FI Enhanced Global High Yield ETN Series B: 15,406,823 shares worth $1.49B.
- Ken Fisher added most to SLB Ltd in Q1 2018, an estimated $408M increase.
- Ken Fisher's biggest Q1 2018 reduction was Barclays ETN+ FI Enhanced Global High Yield ETN, cutting an estimated $1.59B.
- Ken Fisher fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $123M.
- Ken Fisher's ten largest holdings make up 26% of its $75.4B portfolio in Q1 2018.
- Ken Fisher opened 69 new positions and closed 162 in Q1 2018.
- Ken Fisher's portfolio value fell 1.5% quarter-over-quarter to $75.4B.
Based on Fisher Asset Management's 13F filing for Q1 2018, filed 19 Apr 2018.